Related Image: Weed Scientists Take Steps to Protect Rare Orchid |
(Date:11/20/2009)... , STOCKHOLM, November 20 /PRNewswire/ -...he European Investment Fund (EIF) has entered into...o-investment fund will be,managed by Karolinska De...folio of early-stage pharmaceutical and medical te...M Euros in the co-investment fund. The agreement,r...
(Date:11/20/2009)... METTLER TOLEDO recently announ...e webinar, “The Role of Process Analytical T...eering” on December 1, 2009. , ...e The Role of Process Analytical Technology (PAT)... on December 1, Process Analytical Technology (PAT...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)..., NEW YORK, Nov. 19 N...hat it has sent the following letter to its shareh...ctober 30, 2009, of China Biopharmaceuticals Holdi... company based in the People,s Republic of China. ...t in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s p...
Breaking Biology Technology:Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 2Karolinska Development and EIF Start Landmark Co-Investment Fund for Life Science Innovation 3Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3...ndine Biopharma,Corporation (TSX: OBP; AIM: OBP), ...fection-based products, today announced that a pos...f Chronic Periodontitis" will be,presented by Comp...iodontology,s (AAP) annual meeting. This year,s AA...nvention and Trade Center in Seattle,Washington on...
...tCall/ -- Huifeng Bio-,Pharmaceutical Technology, ...eading developer and producer of plant extracts an...utical, nutraceutical and food production in,Xi,an... to enter into a,contractual arrangement with Xi,a...proposed terms of this arrangement, Huifeng will t...
...asdaq: MEDQ ) today announced that its board of d...rien, and Andrew Vogel to join the board, effectiv...new directors, the board of,directors expanded the...ording to MedQuist Chairman of the Board Robert Aq...o further enhance the quality and,experience on th...
Other Biology Technology:Ondine Announces Presentation of Positive Clinical Trial Results at the American Academy of Periodontology's 94th Annual Meeting 2Huifeng Bio-Pharmaceutical (HFGB) Enters into Letter of Intent with Xi'an Qinba Xintong Medical Ltd. 2MedQuist Announces Additions to Board of Directors 2MedQuist Announces Additions to Board of Directors 3HRP-STABILPLUS from AbD Serotec
...he 200RT rotary tables offer precision motorized r...t compatible with Parkers linear positioners and i...lti-axis configurations., , Preloaded, precision ...race preloaded angular contact support bearing , R...
Rabbit Anti-Defender against cell death 1 Polyclonal Antibody, Unconjugated from GenWay Biotech, Inc.
Human IL-1 beta (IL-1F2) ELISpot Development Kit from R&D Systems
Biology Products: